-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490

Benzinga·10/28/2026 13:09:11
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.